Market Overview:
The global acamprosate calcium market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of alcohol addiction and rising demand for effective treatment options. Acamprosate calcium is an FDA-approved drug for the treatment of alcohol addiction and has been found to be effective in reducing relapse rates. The global acamprosate calcium market can be segmented on the basis of type and application. On the basis of type, the market can be segmented into 333mg and 666mg variants. The 333mg variant is more popular than 666mg variant due to its lower dosage requirement and ease of administration. On the basis of application, the market can be segmented into hospital pharmacies and retail pharmacies/drug stores.
Product Definition:
Acamprosate calcium is a medication that is used to help people who are addicted to alcohol. It helps by reducing cravings for alcohol and helping to prevent relapse.
333mg:
333mg is a form of vitamin B3 and helps in maintaining the proper functioning of the brain, nerves, and muscles. Vitamin B3 also known as thiamine plays an important role in fueling cells with energy. It is used to treat diseases such as myasthenia gravis, pernicious anemia, pellagra disease (B3 deficiency), beriberi (B6 deficiency), and kwashiorkor.
666mg:
Acamprosate calcium is a drug used in the treatment of bone metastasis and advanced renal failure. It works by blocking the action of calcium ions, which are required for the formation of kidney stones.
Application Insights:
Based on application, the global acamprosate calcium market is segmented into hospital, drug store and others. The hospital application segment accounted for the largest share in 2017 owing to high usage rates of acamprosate calcium in hospitals for treating alcohol dependence. Acamprosate calcium is available as a generic drug and is manufactured by various companies without any patent protection; hence there are numerous manufacturers offering this product around the world.
The growing prevalence of substance abuse among youth along with rising awareness about treatment facilities that offer complete abstinence programs has resulted in increased demand for residential rehabilitation centers across countries such as India, China and Australia over the past few years. This factor coupled with increasing government initiatives against substance abuse will likely fuel market growth during the forecast period.
In addition, several public organizations including Al-Anon Family Groups International provide support to families affected by alcoholism through group meetings and local chapters worldwide (Al-Anon Family Groups).
Regional Analysis:
North America was the largest market for acamprosate calcium in 2016, with a revenue share of over 35.0%. The region is expected to maintain its dominance throughout the forecast period on account of high product demand as a result of rising incidence rates of addictions and mental disorders coupled with growing awareness about available treatment options. In addition, increasing number of R&D activities by key companies in this region is anticipated to fuel market growth over the next eight years.
Asia Pacific is estimated to be fastest-growing regional market from 2017 to 2030 owing to improving economic conditions and growing disposable income levels in emerging countries such as China and India. Moreover, increasing prevalence rate for substance abuse disorder coupled with government initiatives aimed at reducing social stigma associated with mental health issues are some factors that can be attributed towards rapid growth experienced by this regional segment during recent years.
Growth Factors:
- Increasing number of alcoholics: The number of alcoholics is increasing globally, which is expected to drive the demand for acamprosate calcium.
- Growing awareness about the benefits of acamprosate calcium: There is growing awareness among people about the benefits of acamprosate calcium, which is likely to boost its demand in the coming years.
- Rising incidence of relapse among alcoholics: The incidence of relapse among alcoholics is high, which creates a need for effective treatment options such as acamprosate calcium and drives its market growth.
- Availability of generic versions: The availability of generic versions has made this drug affordable and accessible to a larger population, thereby boosting its demand worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Acamprosate Calcium Market Research Report
By Type
333mg, 666mg
By Application
Hospital, Drug Store
By Companies
Merck Group, Zydus Pharmaceuticals, Mylan, Teva, Glenmark Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Acamprosate Calcium Market Report Segments:
The global Acamprosate Calcium market is segmented on the basis of:
Types
333mg, 666mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck Group
- Zydus Pharmaceuticals
- Mylan
- Teva
- Glenmark Pharmaceuticals
Highlights of The Acamprosate Calcium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 333mg
- 666mg
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acamprosate Calcium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acamprosate calcium is a medication used to treat alcohol dependence. It works by helping people to reduce their drinking and cravings.
Some of the major players in the acamprosate calcium market are Merck Group, Zydus Pharmaceuticals, Mylan, Teva, Glenmark Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acamprosate Calcium Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Acamprosate Calcium Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Acamprosate Calcium Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Acamprosate Calcium Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Acamprosate Calcium Market Size & Forecast, 2018-2028
4.5.1 Acamprosate Calcium Market Size and Y-o-Y Growth
4.5.2 Acamprosate Calcium Market Absolute $ Opportunity
Chapter 5 Global Acamprosate Calcium Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Acamprosate Calcium Market Size Forecast by Type
5.2.1 333mg
5.2.2 666mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Acamprosate Calcium Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Acamprosate Calcium Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acamprosate Calcium Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acamprosate Calcium Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Acamprosate Calcium Analysis and Forecast
9.1 Introduction
9.2 North America Acamprosate Calcium Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Acamprosate Calcium Market Size Forecast by Type
9.6.1 333mg
9.6.2 666mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Acamprosate Calcium Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Acamprosate Calcium Analysis and Forecast
10.1 Introduction
10.2 Europe Acamprosate Calcium Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Acamprosate Calcium Market Size Forecast by Type
10.6.1 333mg
10.6.2 666mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Acamprosate Calcium Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Acamprosate Calcium Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Acamprosate Calcium Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Acamprosate Calcium Market Size Forecast by Type
11.6.1 333mg
11.6.2 666mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Acamprosate Calcium Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Acamprosate Calcium Analysis and Forecast
12.1 Introduction
12.2 Latin America Acamprosate Calcium Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Acamprosate Calcium Market Size Forecast by Type
12.6.1 333mg
12.6.2 666mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Acamprosate Calcium Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Acamprosate Calcium Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Acamprosate Calcium Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Acamprosate Calcium Market Size Forecast by Type
13.6.1 333mg
13.6.2 666mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Acamprosate Calcium Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acamprosate Calcium Market: Competitive Dashboard
14.2 Global Acamprosate Calcium Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck Group
14.3.2 Zydus Pharmaceuticals
14.3.3 Mylan
14.3.4 Teva
14.3.5 Glenmark Pharmaceuticals
